ARCHIVES

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 8 | August 26, 2011

Download PDF Visit The Full Archive

Related Articles

Revised Price Equivalent to Lower Dose of Avastin

November 8, 2012

Where’s The Money for Local Programs? Everyone Wants To Know

February 28, 1975

DCPC Board Commits More Than $100 Million To 15-Year Trial Of Low Fat Diet In Women

October 26, 1990

Also R01 payline likely to fall below 20th percentile in FY04.

September 26, 2003

Research Base Would Be Increased In Guideline Change

November 9, 1990

ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer.

March 24, 2006